Company - MIMETAS : Overview | A2A
Explore
Companies
MIMETAS
OverviewBrands / Suppliers
Mimetas develops high-throughput healthy and diseased organ-on-a-chip models in the OrganoPlate®, a screening-compatible microfluidics platform that supports the recreation of native tissue structures, and their interaction with compounds, signaling factors, disease triggers, and co-cultured cell types.
